$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
恩杂鲁胺服用说明
2025-10-19 11:44:20
Check Details
恩杂鲁胺的使用说明书
2025-10-19 11:44:20
Check Details
恩杂鲁胺是治什么的药物?
2025-10-19 11:44:20
Check Details
恩杂鲁胺是何药物?
2025-10-19 11:44:20
Check Details
恩杂鲁胺和阿比特龙的治疗效果有何不同?
2025-10-19 11:44:20
Check Details
怎么吃恩杂鲁胺呢?
2025-10-19 11:44:20
Check Details
恩杂鲁胺服用几天病情能够好转?
2025-10-19 11:44:20
Check Details
恩杂鲁胺能够吃多久?
2025-10-19 11:44:20
Check Details
恩杂鲁胺能治疗什么癌症?
2025-10-19 11:44:20
Check Details
恩杂鲁胺可以吃多久?
2025-10-19 11:44:20
Check Details
恩杂鲁胺多少钱?
2025-10-19 11:44:20
Check Details
恩杂鲁胺的使用方法以及服用剂量
2025-10-19 11:44:20
Check Details
1
2
...
1323
1324
1325
1326
1327
1328
1329
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
3
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
4
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
5
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
6
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
7
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
8
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
9
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
10
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
11
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
12
Pemigatinib for FGFR2-Rearranged Cholangiocarcinoma: Eligibility, Response Limits, Hyperphosphatemia and Ocular Monitoring